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Change is: Mutation
Gene/Locus
Name: breast cancer 1, early onset
Symbol: BRCA1
Genbank accession number: L78833
OMIM accession number: 113705
Locus specific database: Breast Cancer Information Core, BIC
http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/ Bic/
Chromosomal location: 17q12-24
Inheritance: autosomal dominant
Mutation / polymorphism name
Nucleotide change-Systematic name:c.2754G>T
Amino acid change-Trivial name: E879X
Mutation / polymorphism type: nonsense
Polymorphism frequency:
Detection method: direct sequencing
Detection conditions: Forward primer: 5'-acagtcgggaaacaagcatagaa-3' Reverse primer:  5'-
tttggcattatcaactggcttatc-3' Standard 30 cycle PCR, annealing
temperature 60 C
Diagnosis method developed: Mutation disrupts normal MboII restriction site
Evidence for existence and effect of mutation:
Yes No Don’t know
1. Base change found on repeat PCR sample X
2. Base change segregates or appears with trait X
3. Base change affects conserved residue X
4. Expression analysis supports hypothesis for causation X
5. Normals tested (50 required) X
Ancillary data
1. Haplotype association :
2. Ethnic background/Population association : Chinese ethnic group
3. Geographic association : Malaysia
4. Frequency (of mutation) in population:
5. Clinical phenotype of proband : Unilateral breast cancer at age of 58 years
6. Homologous allele (if recessive trait):
7. PIC: (if microsatellite)
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8. Other:
9. Present in HGMD listing:
(http://www.cf.ac.uk/uwcm/mg/hgmd0.html)
Yes: No: X
Comments
Information on BRCA1 mutations in non-Caucasians is lacking (Szabo and King, 1997).  Our patient
was a 58 year old postmenopausal nulliparous woman of Malaysian Chinese descent who presented with
grade III infiltrating ductal carcinoma (T3 N0 M0) of her left breast.  The tumor was negative for estrogen
receptor by immunohistochemistry but strongly positive for c-erbB-2 and p53.  The patient underwent
mastectomy  with axillary clearance, local radiotherapy, adjuvant chemotherapy and tamoxifen.  She had
no known family history of breast cancer.   Her sister had been diagnosed with cervical cancer about 2
decades previous, while her paternal grandmother died from an abdominal tumor (details not known).
Direct sequencing of the entire BRCA1 coding region (Miki et al., 1994) of our patient showed that she
was heterozygous for a polymorphism  c.2685T>C (Y856H) (Tang et al., 1999) and a novel mutation,
c.2754G>T(E879X)  both of which were in exon 11.  The mutation is predicted to result in the lost of the
C-terminal region (Monteiro et al., 1996).
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